Who are the key players in North America Allergy Diagnostics Market industry?

The top five players in the North America Allergy Diagnostics Market include Thermo Fisher Scientific, PerkinElmer Inc., Siemens Healthineers, Danaher Corporation, and bioMérieux SA. These companies lead the market with advanced allergy testing solutions, broad product portfolios, and strong distribution channels, supporting growing demand for accurate allergy diagnostics.

What is the North America Allergy Diagnostics Market growth?

The North America Allergy Diagnostics Market is experiencing robust growth, projected to expand at a CAGR of over 7% from 2023 to 2028. Key growth factors include increasing allergy prevalence, rising awareness, and innovations in diagnostic techniques by companies like Thermo Fisher Scientific.

Which segment accounted for the largest North America Allergy Diagnostics Market share?

In 2023, the 'in vitro diagnostics' application segment held the largest market share in North America. This is attributed to the high accuracy, ease of use, and non-invasive nature of in vitro tests such as ImmunoCAP, widely adopted in clinical and laboratory settings for efficient allergy detection.

What are the factors driving the North America Allergy Diagnostics Market?

Key drivers for the North America Allergy Diagnostics Market include increasing rates of allergic diseases, improved reimbursement policies, and advancements in diagnostic technologies. Companies like PerkinElmer are investing in new product launches and strategic collaborations to improve testing efficiency and accessibility.

Which type accounted for the largest North America Allergy Diagnostics Market share?

The 'Consumables' segment, which includes reagents, test kits, and assays, accounted for the largest market share. High demand for repeated testing and routine use in laboratories propel this segment’s dominance, with major contributions from companies like Siemens Healthineers.

Home Healthcare

North America Allergy Diagnostics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Allergy Diagnostics Market
Brand: Bussiness Insights

North America Allergy Diagnostics Market Market: by Type (Allergen Assay Kits, Instruments, Consumables), Application (Inhaled Allergens, Food Allergens, Drug Allergens, Others), Distribution Channels (Hospital-based Laboratories, Diagnostic Laboratories, Academic Research Institutes, Others), Technology (Immunoassay, ELISA, ImmunoCAP, LC-MS/MS, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20503 | Author: Lena

RD TOC Segmentation Research Methodology Request For Free Sample Copy

North America Allergy Diagnostics Market Outlook, Growth, and Insights (2025-2035)

The North America Allergy Diagnostics market is witnessing robust expansion, propelled by the increasing prevalence of allergic disorders and the adoption of advanced diagnostic technologies. The market is segmented by type, application, technology, distribution channel, organization size, and country, with a focus on innovations tailored to meet the region's diverse diagnostic needs. Enhanced clinical awareness and government health initiatives have further fueled demand, while leading companies compete through portfolio diversification and technological integration. Looking forward, the sector is poised for sustained growth, especially as personalized medicine and at-home testing become mainstream, providing significant opportunities for stakeholders across the value chain.

Latest Market Dynamics

Key Drivers

Rising Prevalence of Allergic Diseases – The number of individuals diagnosed with allergies continues to grow across North America due to environmental changes and evolving lifestyles. This persistent trend fuels the demand for comprehensive and accurate allergy diagnostics. For instance,

Shift Towards At-Home Testing Kits – Convenience-driven consumers are increasingly opting for self-administered allergy tests. Danaher Corporation has launched customizable at-home allergy diagnosis solutions, meeting demand for privacy and ease of access.
Integration of Artificial Intelligence in Diagnostics – AI integration enables rapid interpretation and personalized recommendations. In 2025, Eurofins Scientific introduced AI-powered data analytics to enhance diagnostic accuracy and patient care outcomes.

Expansion in Untapped Rural and Remote Areas – Growing adoption of telehealth and portable diagnostic kits fosters market entry into areas with limited access to traditional healthcare facilities. Omega Diagnostics Group is actively piloting mobile clinics across underserved North American communities.
Personalized Allergy Profiling – As healthcare shifts toward personalization, bioMérieux has invested in precision diagnostic platforms that tailor testing to individual immune responses, unlocking new market segments for targeted therapies.

Stringent Regulatory Requirements – Complex and evolving regulations pose challenges for market entry and compliance. HYCOR Biomedical faces ongoing hurdles in gaining timely regulatory approvals across the region.
Shortage of Skilled Laboratory Professionals – The increasing complexity of allergy diagnostics requires skilled technicians, making workforce shortages a persistent bottleneck. Lincoln Diagnostics is investing in specialist training programs to address this gap.

High Cost of Advanced Diagnostic Solutions – The financial burden of adopting cutting-edge diagnostic tools can deter smaller labs and clinics. Smaller healthcare organizations cite upfront investments as a major impediment to upgrading their facilities, particularly affecting adoption rates of solutions from Stallergenes Greer.
Limited Public Awareness in Emerging Segments – Persistent gaps in patient and physician knowledge about newer diagnostic options restrain growth, especially in allergen categories beyond food and inhaled types. Romer Labs emphasizes the need for education and outreach in its latest strategic roadmap.

The market for allergy diagnostics in North America is distinctly characterized by the dominance of Allergen Assay Kits, which capture a significant share due to their widespread use in laboratory and point-of-care settings. Instruments and consumables follow, leveraging technological advancements and increased clinical adoption. This segmentation highlights a preference for flexible, rapid, and scalable testing methodologies that cater to broad diagnostic requirements across hospital-based and independent laboratories.

The application landscape is led by inhaled allergens, reflecting the high incidence of respiratory allergies such as pollen, dust mite, and mold-related conditions throughout North America. Food allergen diagnostics are the second-largest segment, driven by rising food allergies and regulatory mandates, while drug allergen testing also shows growing importance. Laboratories increasingly demand cost-effective and multiplexed application solutions to address this broad spectrum of diagnostic needs.

Between 2020 and 2035, the North America Allergy Diagnostics market is projected to expand significantly, fueled by surging diagnostic awareness, evolving reimbursement models, and continuous pipeline innovations. The market is estimated to reach a valuation of USD 1,580 Million in 2025, with growth rates accelerating as players invest in automation and AI integration. This robust trajectory signifies the region’s stance as a global frontrunner in diagnostic modernization.

Year-over-year (YOY) growth in the North America Allergy Diagnostics market is characterized by strong initial gains, stabilizing as the market matures and saturation increases post-2030. Notable peaks between 2020 and 2028 are attributed to the uptake of advanced multiplexing platforms and expansion of testing indications. The YOY growth rate averages 4.4% through 2025, before gradually moderating as the market consolidates.

The United States maintains a commanding presence in the North America Allergy Diagnostics market, owing to advanced infrastructure, high diagnostic penetration, and the presence of leading industry players. Canada and Mexico follow, benefitting from rising healthcare investments and evolving diagnostic guidelines; however, their combined share is still eclipsed by the US. Regional differences reinforce the importance of strategic localization in product deployment and education initiatives.

Market leadership is tightly held by a cohort of established players, with Thermo Fisher Scientific, Siemens Healthineers, and Danaher Corporation leading innovation and market presence. These companies benefit from extensive product portfolios, global reach, and dedicated R&D investments. A long tail of other participants continues to challenge the leaders through niche specializations and regional customization.

Hospital-based laboratories constitute the largest buyer segment in North America, accounting for nearly half the market share. Their advanced infrastructure and demand for high-throughput diagnostic capabilities drive bulk procurement. Diagnostic laboratories, including independent and reference labs, represent the second-largest segment, embracing innovation to expand their capabilities and service delivery. Academic and research institutes round out the top buyer categories.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	1580
Regions	US, Canada, Mexico
Segments	By Type, By Application, By Technology, By Distribution Channel, By Organization Size
Players	Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, bioMérieux, Omega Diagnostics Group, Eurofins Scientific, Stallergenes Greer, HYCOR Biomedical, Lincoln Diagnostics, Romer Labs, R-Biopharm, PerkinElmer, AllerGenis, Mindray Medical International

June 2024: Siemens Healthineers launches Atellica Allergy Testing platform in US, enhancing multiplexed diagnostic capabilities.
July 2024: Thermo Fisher Scientific introduces next-gen ImmunoCAP solutions for allergy profiling, targeting expanded clinical adoption.
August 2024: Eurofins Scientific integrates AI-driven analytics in allergy diagnostics, improving detection accuracy and reporting times.
September 2024: Omega Diagnostics Group unveils mobile allergy diagnostic clinics targeting underserved rural populations in North America.
October 2024: Danaher Corporation rolls out direct-to-consumer at-home allergy test kits, supporting the growing home diagnostics trend.

About the Author

Lena

Senior Research Consultant

Lena is a Senior Research Consultant specializing in market research, industry analysis, and business consulting across Healthcare. Lena brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Lena has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America Allergy Diagnostics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Allergy Diagnostics Market Outlook, Growth, and Insights (2025-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

North America Allergy Diagnostics Market Share by Type, 2025

North America Allergy Diagnostics Market Share by Application, 2025

North America Allergy Diagnostics Market Revenue, 2020-2035 (USD Million)

North America Allergy Diagnostics Market Year-over-Year Growth, 2020-2035 (%)

North America Allergy Diagnostics Market Regional Share (%), 2025

North America Allergy Diagnostics Market Players Share (%), 2025

North America Allergy Diagnostics Market Buyers Share (%), 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports